COM:ACUTUSMEDICAL
Acutus Medical
- Stock
Last Close
0.06
22/11 20:00
Market Cap
832.20K
Beta: -
Volume Today
44.46K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 5.71M - | 10.69M 87.12% | 14.68M 37.34% | 14.87M 1.26% | 8.80M 40.79% | ||
average payables | 2.74M - | 6.07M 121.72% | 7.89M 29.94% | 6.12M 22.46% | 3.74M 38.87% | ||
average receivables | 213.50K - | 1.21M 467.45% | 2.90M 139.08% | 12.36M 326.69% | 16.22M 31.23% | ||
book value per share | -7.82 - | -13.07 67.12% | 11.10 184.88% | 3.69 66.75% | 2.65 28.21% | ||
capex per share | -0.12 - | -0.78 541.22% | -0.98 26.89% | -0.35 64.63% | -0.14 59.59% | ||
capex to depreciation | -0.96 - | -4.23 340.18% | -2.88 32.02% | -1.45 49.66% | -0.56 61.40% | -0.41 27.00% | |
capex to operating cash flow | 0.06 - | 0.24 296.57% | 0.13 44.91% | 0.10 24.09% | 0.05 53.18% | 0.01 84.22% | |
capex to revenue | -0.94 - | -4.72 401.99% | -1.33 71.92% | -0.58 56.44% | -0.24 57.87% | -0.08 69.10% | |
cash per share | 1.05 - | 4.16 294.76% | 11.49 176.41% | 3.52 69.39% | 2.49 29.28% | ||
days of inventory on hand | 145.95 - | 332.66 127.92% | 297.67 10.52% | 181.90 38.89% | 152.44 16.19% | ||
days payables outstanding | 77.62 - | 153.30 97.50% | 189.89 23.87% | 83.35 56.10% | 54.00 35.22% | ||
days sales outstanding | 27.64 - | 33.85 22.48% | 93.15 175.19% | 76.81 17.53% | 470.33 512.30% | 1.37K 190.68% | |
debt to assets | 1.00 - | 0.39 60.87% | 0.21 45.30% | 0.27 25.33% | 0.29 8.90% | 0.71 144.89% | |
debt to equity | -0.20 - | -0.18 7.17% | 0.32 278.16% | 0.43 32.33% | 0.52 20.62% | -43.78 8,551.78% | |
dividend yield | |||||||
earnings yield | -0.11 - | -0.26 142.96% | -0.31 19.05% | -1.26 306.86% | -1.22 3.66% | ||
enterprise value | 462.81M - | 489.43M 5.75% | 344.50M 29.61% | 119.04M 65.44% | 45.84M 61.49% | 19.31M 57.88% | |
enterprise value over ebitda | -12.76 - | -7.31 42.73% | -3.96 45.77% | -1.09 72.42% | -0.55 49.71% | 0.47 185.54% | |
ev to operating cash flow | -13.70 - | -8.74 36.19% | -4.04 53.73% | -1.19 70.48% | -0.54 54.85% | -0.63 16.11% | |
ev to sales | 213.67 - | 172.58 19.23% | 40.70 76.42% | 6.90 83.06% | 2.80 59.37% | 6.37 127.39% | |
free cash flow per share | -2.13 - | -4.02 88.98% | -8.45 110.38% | -3.83 54.71% | -3.14 17.87% | ||
free cash flow yield | -0.08 - | -0.15 88.98% | -0.29 93.51% | -1.12 282.62% | -2.73 143.53% | ||
graham net net | -8.21 - | -14.77 79.79% | 6.42 143.47% | 1.66 74.10% | 1.22 26.72% | ||
graham number | 22.37 - | 45.07 101.50% | 47.24 4.82% | 18.91 59.98% | 9.13 51.71% | ||
income quality | 0.71 - | 0.58 18.18% | 0.84 44.75% | 0.85 1.42% | 2.15 153.40% | 0.78 63.72% | |
intangibles to total assets | 0 - | 0.15 Infinity% | 0.09 39.99% | 0.10 9.29% | 0.01 88.18% | 0 100% | |
interest coverage | -7.22 - | -3.26 54.84% | -16.59 409.00% | -19.75 19.06% | -5.31 73.12% | -7.97 50.13% | |
interest debt per share | 1.85 - | 3.67 98.91% | 4.08 11.26% | 1.78 56.35% | 1.55 12.84% | ||
inventory turnover | 2.50 - | 1.10 56.13% | 1.23 11.75% | 2.01 63.65% | 2.39 19.32% | ||
invested capital | -0.20 - | -0.18 7.17% | 0.32 278.16% | 0.43 32.33% | 0.52 20.62% | -43.78 8,551.78% | |
market cap | 446.57M - | 457.75M 2.50% | 328.65M 28.20% | 97.71M 70.27% | 32.57M 66.67% | ||
net current asset value | -135.83M - | -248.81M 83.17% | 85.44M 134.34% | 62.22M 27.17% | 59.45M 4.46% | -8.59M 114.45% | |
net debt to ebitda | -0.45 - | -0.47 5.64% | -0.18 61.46% | -0.20 7.46% | -0.16 18.74% | 0.47 395.48% | |
net income per share | -2.84 - | -6.91 142.96% | -8.94 29.43% | -4.31 51.84% | -1.40 67.51% | ||
operating cash flow per share | -2.00 - | -3.24 61.69% | -7.47 130.35% | -3.48 53.41% | -3.00 13.70% | ||
payables turnover | 4.70 - | 2.38 49.37% | 1.92 19.27% | 4.38 127.81% | 6.76 54.36% | ||
receivables turnover | 13.21 - | 10.78 18.35% | 3.92 63.66% | 4.75 21.26% | 0.78 83.67% | 0.27 65.60% | |
research and ddevelopement to revenue | 8.81 - | 13.41 52.25% | 3.95 70.52% | 2.12 46.24% | 1.72 19.03% | 1.03 40.21% | |
return on tangible assets | -1.85 - | -1.34 27.65% | -0.58 56.34% | -0.81 38.47% | -0.30 62.80% | 0.53 277.85% | |
revenue per share | 0.13 - | 0.16 27.74% | 0.74 351.91% | 0.60 18.80% | 0.58 4.10% | ||
roe | 0.36 - | 0.53 45.38% | -0.81 252.48% | -1.17 44.83% | -0.53 54.74% | -32.80 6,111.57% | |
roic | 0.32 - | 0.49 53.54% | -0.54 209.67% | -0.75 39.88% | -0.23 69.24% | 0.99 526.20% | |
sales general and administrative to revenue | 6.15 - | 9.47 53.82% | |||||
shareholders equity per share | -7.82 - | -13.07 67.12% | 11.10 184.88% | 3.69 66.75% | 2.65 28.21% | ||
stock based compensation to revenue | 0.96 - | 1.06 10.41% | 1.43 35.45% | 0.80 44.28% | 0.57 27.97% | 1.12 95.45% | |
tangible asset value | -131.82M - | -241.95M 83.54% | 108.90M 145.01% | 88.69M 18.56% | 73.44M 17.20% | -879K 101.20% | |
tangible book value per share | -7.82 - | -14.01 79.06% | 9.55 168.16% | 3.10 67.58% | 2.59 16.23% | ||
working capital | -2.92M - | 50.55M 1,829.25% | 129.48M 156.16% | 107.78M 16.76% | 98.00M 9.08% | 27.31M 72.13% |
All numbers in USD (except ratios and percentages)